Nippon Life Global Investors Americas’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-479,080
Closed -$24.5M 139
2022
Q4
$24.5M Hold
479,080
1.62% 22
2022
Q3
$21M Sell
479,080
-30,040
-6% -$1.46M 1.47% 22
2022
Q2
$26.7M Sell
509,120
-57,980
-10% -$2.95M 1.73% 9
2022
Q1
$29.4M Buy
567,100
+45,040
+9% +$2.34M 1.57% 14
2021
Q4
$30.8M Sell
522,060
-34,160
-6% -$1.69M 1.46% 13
2021
Q3
$23.9M Buy
+556,220
New +$24.6M 1.25% 17
2021
Q1
Sell
-415,080
Closed -$15.3M 162
2020
Q4
$15.3M Sell
415,080
-34,367
-8% -$1.26M 0.91% 30
2020
Q3
$15.7M Sell
449,447
-128,208
-22% -$4.49M 1.03% 26
2020
Q2
$17.9M Sell
577,655
-19,731
-3% -$670K 1.28% 20
2020
Q1
$18.5M Buy
597,386
+208,281
+54% +$7.1M 1.62% 19
2019
Q4
$14.5M Sell
389,105
-15,958
-4% -$568K 0.98% 33
2019
Q3
$13.8M Sell
405,063
-14,629
-3% -$532K 1.02% 30
2019
Q2
$17.2M Buy
419,692
+37,828
+10% +$1.5M 1.31% 24
2019
Q1
$15.4M Buy
+381,864
New +$15.3M 1.24% 26
2015
Q1
Sell
-141,067
Closed -$4.17M 127
2014
Q4
$4.17M Buy
141,067
+21,153
+18% +$607K 0.38% 90
2014
Q3
$3.36M Sell
119,914
-461,072
-79% -$12.9M 0.32% 104
2014
Q2
$16.4M Buy
580,986
+136,525
+31% +$3.89M 1.54% 14
2014
Q1
$13.5M Buy
444,461
+365,137
+460% +$10.9M 1.34% 18
2013
Q4
$2.31M Sell
79,324
-272,297
-77% -$7.92M 0.23% 117
2013
Q3
$9.58M Sell
351,621
-26,993
-7% -$734K 1.04% 34
2013
Q2
$10.1M Buy
+378,614
New +$10.5M 1.11% 30

Other funds holding PFE

Nippon Life Global Investors Americas's PFE Position: Q1 2023 in Review

Nippon Life Global Investors Americas sold out of Pfizer (PFE) in Q1 2023, closing a stake of 479,080 shares — an estimated $24.5M sold.

Nippon Life Global Investors Americas first reported a position in PFE in Q2 2013 and held it in 21 quarters. The position peaked at $30.8M in Q4 2021. 3,104 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Nippon Life Global Investors Americas reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 479,080 Pfizer shares in Q1 2023, an estimated $24.5M.
  • Nippon Life Global Investors Americas first reported a position in Pfizer in Q2 2013 and held it in 21 quarters.
  • Nippon Life Global Investors Americas's Pfizer position peaked at $30.8M in Q4 2021.
  • 3,104 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2023, filed 15 May 2023.